Therapeutic effects of Kanglaite injection combined with chemotherapy on advanced non-small cell lung cancer (NSCLC).

Abstract

Abstract

Objective: To study the therapeutic effect of Kanglaite injection combined with chemotherapy in the treatment of late stage non-small cell lung cancer (NSCLC), and also to observe the effect of the combination treatment on immune function. Methodology: 92 patients with advaned stage of non-small cell lung cancer who admitted to First Hospital of ZiBo city hospital from May 2017 to October 2018 were randomly divided into experimental group and control group, with 46 cases respectively. The control group was treated with chemotherapy only while the experimental group was treated with Kanglaite injection combined with chemotherapy which was the basic treatment for patients, and the total treatment effective rate, adverse reaction rate and immune index of the treatments on two groups were compared. Result: The total treatment effective rate of the experimental group was 80.43%, which was significantly higher than that of the control group, which was 63.04%. The incidence of adverse reactions in the experimental group was 36.96%, which was lower than that of the control group (78.26%). The immune indexes of the experimental group (CD3+, CD4+, IgG, IgA) were better than that of the control group, respectively. The differences between the two groups were statistically significant (P<0.05).Conclusion: During the chemotherapy of late stage or advanced non-small cell lung cancer, the addition use of Kanglaite injection has a significant effect on improving tumor control and reducing the side effects of chemotherapy, and helps to improve the immune function of patients, thus it is worth promoting.

References

Hou Encun, Chen Jie, Gan Lu et al. Systematic evaluation of the efficacy of Kanglaite combined with GP regimen in the treatment of advanced non-small cell lung cancer [J]. Modern Oncology Medicine, 2015 (7): 960-965.

Wang Yuan, Hui Shuang, Li Min et al. Clinical study of Kanglaite injection in the treatment of advanced non-small cell lung cancer with gemcitabine combined with cisplatin regimen [J]. Chinese Journal of Clinical Pharmacology, 2017, 33(23): 2354-2356, 2360.

Deng Xinna, Zhao Shufang, Li Yang et al. Therapeutic effect of Kanglaite injection combined with chemotherapy on elderly patients with advanced non-small cell lung cancer [J]. Modern Journal of Integrated Traditional Chinese and Western Medicine, 2015 (18): 1951-1953, 1957.

Zeng Hongxue, Zeng Chunsheng, Liu Lianbin et al. Effects of Kanglaite combined with gefitinib on immune function and quality of life in patients with advanced non-small cell lung cancer[J]. Chinese Journal of Practical Diagnosis and Therapy, 2014, 28(9): 930-931.

Jia Ting, Peng Qi. Evaluation of efficacy and safety of Kanglaite combined with chemotherapy versus chemotherapy alone in advanced non-small cell lung cancer: meta-analysis [J].International Journal of Respiration,2017,37(2):116-123.

Yao Jun, Song Xiao. Clinical analysis of gemcitabine and cisplatin combined with Kanglaite injection in the treatment of advanced non-small cell lung cancer [J]. Journal of Clinical and Experimental Medicine, 2017, 16(12): 1195-1198.

Qin Yinzhong. The effect of Kanglaite combined with radiotherapy on non-small cell lung cancer and immune function of patients [J].The Practical Journal of Cancer, 2016, 31(4):578-580.

Hang Meng, Chen Shubo, Sun Qing et al. Efficacy and safety of GP regimen combined with Kanglaite injection in the treatment of advanced non-small cell lung cancer[J].The Practical Journal of Cancer,2017,32(2):289- 291.